Asian Regulatory Discussions: ASEANMed Nations Make Device Progress Despite Pandemic
ASEANMed challenges the need for embassy legalization of documents
Executive Summary
Medtech industry representatives from Thailand, Myanmar, Indonesia, Singapore and the Philippines gave updates on regulatory actions being taken to control COVID-19 and other regulatory initiatives at local and ASEANMed level during a roundtable session.
You may also be interested in...
UK/EU Free-Trade Deal Sees Hopes Of Mutual Recognition Of Medtech Regs Fade
“No deal” is finally off the table for the UK trade in goods, after an 11th hour deal was agreed with the EU. But for UK medtech trade and regulation, the decision effectively means a “hard Brexit.”
Thailand Rolls Out IMDRF-Based Risk Classifications For Devices And Diagnostics
Thailand has opted to align with IMDRF principles on the classification of devices. The change also brings the Thai FDA into line with Asean Medical Device Directive principles.
Philippines Gets Moving On Reg Reform: Asian Medtech Associations Regulatory Networking, October 2018
The Asian Medtech Associations Regulatory Networking discussions this month focus on regulatory reforms in the Philippines, where good progress is being made on embedding a new set of medical device, IVD and labeling regulations. Also, updates from Thailand, Hong Kong and India. This series is hosted by Medtech Insight, along with the Asia Regulatory and Quality Consultancy (ARQon) and the Asia Regulatory Professionals Association (ARPA).